Premium
Coronary artery disease in lung transplant patients
Author(s) -
Sinha Neeraj,
Balayla Galit,
Braghiroli Joao
Publication year - 2020
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.14078
Subject(s) - medicine , contraindication , coronary artery disease , perioperative , revascularization , lung transplantation , cardiology , population , transplantation , disease , lung , intensive care medicine , surgery , myocardial infarction , pathology , alternative medicine , environmental health
Coronary artery disease (CAD) is a pathology often found in patients with end‐stage lung disease. Although in the past CAD might have been considered an absolute contraindication, modern revascularization techniques have helped increase the number of transplants performed in this population. However, discrepancies in the guidelines for perioperative evaluation and risk mitigation strategies for the ischemic cardiac burden are present in the current literature. This is a review of the available data regarding perioperative evaluation, revascularization tactics, postoperative management, and survival rate that patients with different grades of coronary artery disease present after lung transplantation.